By Buy This GLP Editorial Team
KairoRx review
An access fee excludes the brand
KairoRx displays low introductory compounded prices and separate branded access fees. Both require an actual continuation quote before comparison.
A comparable monthly medication price is not available. See the plan details below for published fees, medication costs and payment terms.
The bottom line
KairoRx distinguishes brand-access fees from medication costs. Keep them separate when budgeting. Keep those costs separate. Pharmacy charges come on top. Compounded options also have higher rates after the opening month. Optional digital-advisor charges also deserve attention.
Disclosure: Buy This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
What the figure does not cover
Fees, terms and cancellation at KairoRx
- Outside the headline
- Branded medication is a separate pharmacy expense. The AI advisor can carry its own subscription charge outside qualifying treatment access. Confirm testing and shipping inclusions for the selected offer.
- Prepay
- Plans are monthly unless a longer discounted term is selected. Quarterly averages require greater commitment than flexible monthly purchases.
- Cancellation
- The terms describe account cancellation. Dispensed-prescription refund conditions are addressed separately. Confirm the next processing date. Stop any optional advisor subscription separately if no longer wanted.
- Shipping
- The homepage advertises expedited delivery. Pharmacy preparation and carrier performance determine timing under the terms. Confirm whether the chosen prescription includes shipment and when processing actually begins.
Pricing transparency
How KairoRx publishes its prices
The table separates first-month semaglutide and tirzepatide promotions from later rates. Ozempic and Zepbound access fees explicitly exclude the medication. Compare the full proposed prescription cost, not the smallest number in the table.
At a glance
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
The seller
What KairoRx is
KairoRx is an online service platform connecting patients with medical professionals and pharmacies. It offers weight-care prescriptions alongside other health services and an AI-advisor feature.
How it works
Payment follows provider approval, according to the site. The described service includes messaging and individualized treatment support. Ask whether recommended tests, added products or optional advice create separate payments.
Branded or compounded
Compounded semaglutide and tirzepatide appear beside branded drug access offers. Those are different purchases with different billing. Compounded medicine is not FDA approved. Paying for access does not establish branded medication supply.
Where the money holds, and where it moves
Predictable
- Separate brand-drug billing clearly noted
- Intro and continuing rates distinguished
- Charging described after clinical approval
Moves, or is not stated
- Optional advisor may add a subscription
- Dose can affect some therapies’ cost
- Full refund conditions require another policy
Who this is worth it for
A buyer who will compare the precise recurring plan and identify optional add-ons.
Who should price elsewhere
Someone reading a branded access charge as an all-in medication price.
The molecules
What KairoRx prescribes, and the evidence for it
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Oral Semaglutide 50 mg and the Injection: A 30-Study Systematic Review
A 2026 review of 30 studies put the 50 mg tablet at −15.1% in OASIS 1 and the 2.4 mg injection at −14.9% in STEP 1, two separate trials. Bioavailability is about 1% for the tablet, against 89% injected.
- Is Tirzepatide Worth the Extra Cost Over Semaglutide?
The premium buys measured extra weight loss: 20.2 percent against 13.7 percent in a head-to-head trial. On heart attacks and strokes it buys nothing measurable.
Priced against
Sellers to price beside KairoRx
- SkinnyRx
Buyers choosing tirzepatide who want its standing rate before an intake
See SkinnyRx → - ShedRx
Buyers who want an approved branded drug through a routed pharmacy
See ShedRx → - RxSpan MD
Buyers who want a term discount without committing much money to get it
See RxSpan MD →
More GLP-1 telehealth sellers priced end to end: BeyondMDBig Easy Weight LossBiltRxBionomy HealthBioverseBlis MD
Sponsored alternative
SkinnyRx
Buyers choosing tirzepatide who want its standing rate before an intake
Check SkinnyRx availability →Frequently asked
Does the lowest first-month amount recur?
Is a brand access payment a pharmacy payment?
Provider information
Plans and terms behind the assessment
Checked . Confirm current terms before paying.
Or go back to the price desk and compare KairoRx against every seller on it.